News

MetaVia Inc.: MetaVia Doses First Patient in the 48 mg MAD Cohort of Its Phase 1 Clinical Trial Evaluating DA-1726 for the Treatment of Obesity to Further Explore Maximum ...
Top-Line Data Expected in the Fourth Quarter of 2025 CAMBRIDGE, Mass., July 9, 2025 /PRNewswire/ -- MetaVia Inc. (Nasdaq: MTVA), a clinical-stage biotechnology ...
Ultragenyx And Mereo Biopharma Announce UX143 Phase 3 Orbit Study For Osteogenesis Imperfecta Progressing To Final Analysis
Data from Orbit and Cosmic studies expected around the end of the yearNOVATO, Calif., July 09, 2025 (GLOBE NEWSWIRE) -- Ultragenyx Pharmace ...
Rhythm Pharmaceuticals, Inc.: Rhythm Pharmaceuticals Announces Oral MC4R Agonist Bivamelagon Achieved Statistically Significant, Clinically Meaningful BMI Reductions in Placebo ...
Bivamelagon achieved BMI reductions in patients with acquired hypothalamic obesity of -9.3% and -7.7% in 600mg and 400mg cohorts, respectively, at 14 weeks -- -- Post-hoc analysis showed BMI reduction ...
Stalker 2: Heart of Chornobyl is coming to PS5 later this year
Stalker 2: Heart of Chornobyl is coming to PS5. On Wednesday, developer GSC Game World said the shooter will launch on Sony's ...
The Healthy @Reader's Digest on MSN10h
A Major Grocer Just Announced a Bread Recall in One State
Thirteen types of bakery products are impacted, says a popular supermarket chain, so make sure your loaves at home are in the ...
Bitcoin Solaris Mobile Mining Debuts On Lbank With Revolutionary App
The Solaris Nova App is the centerpiece of Bitcoin Solaris's Universal Mining model. It's not just another mining program, it ...